Serotoninergic activity in turn interferes with dopaminergic signal in the mesolimbic system and can also lead to an increase of prolactin levels with subsequent hypogonadotropic hypogonadism (114–116). This evidence concerns the gene PRL and hypogonadotropic hypogonadism.